94 %HPV DNA detection was successful in 47 (94.0%) samples.
Mauritanieinfection à HPVpublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
Gold tier: mechanically validated evidence, with its primary source.
13 evidence items · page 1 / 1
94 %HPV DNA detection was successful in 47 (94.0%) samples.
Mauritanieinfection à HPVpublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
86.5 %Anopheles multicolor and An. arabiensis fourth-instar larvae survival rates at 17.5 g/l NaCl were 86.5% and 75%, respectively.
Mauritaniepaludismeobserved 2016-2017published 2020Parasites & vectorsPubMeddocument of 4 observations
93.6 %The majority (93.6%) of HPV-positive biopsies contained at least one HPV type covered by the 9-valent Gardasil-9 vaccine.
Mauritanieinfection à HPVpublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
40.9 %40.9% of HPV-positive biopsies were infected by multiple vaccine HPV genotypes.
Mauritanieinfection à HPVpublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
760 casesSince the beginning of 2026, a total of 760 cases (232 confirmed; 528 suspected) and two deaths (CFR: 0.26%) of dengue fever have been reported from four AU MS: CAR, Mali, Mauritania, and Senegal.
Mali · Mauritanie · Sénégaldengueobserved 2026Africa CDCdocument of 6 observations
28 %Among the fifty biopsies, 28.0% were from women suffering from CIN2/3.
Mauritanielésions précancéreuses du col (CIN)published 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
8 %Among the fifty biopsies, 8.0% corresponded to adenocarcinomas (ADC).
Mauritanieadenocarcinomaspublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
64 %Among the fifty biopsies, 64.0% corresponded to squamous cell carcinomas (SCC).
Mauritaniesquamous cell carcinomaspublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
40.4 %The most prevalent HR-HPV genotypes were HPV-45 (40.4%), HPV-16 (38.3%), HPV-39 and HPV-52 (23.4%), HPV-33 (17.0%), HPV-18 (14.9%), HPV-35 (4.2%), and HPV-56 (2.1%).
Mauritanieinfection à HPVpublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
72 %Among the fifty biopsies, 72.0% were from women suffering from invasive cervical cancer (ICC).
Mauritaniecancer du col de l'utéruspublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
62,315 casesIn 2025, a total of 62,315 cases (12,909 confirmed; 156 probable; 49,250 suspected) and 139 deaths (CFR: 0.22%) of dengue fever have been reported from 11 AU MS: Burkina Faso, Cabo Verde, Comoros, Guinea, Kenya, Mali, Mauritania, Mauritius, Nigeria, Senegal, and Sudan.
Burkina Faso · Guinée · Kenya · Mali · Mauritanie · Nigeria · Sénégal · Soudandengueobserved 2025Africa CDCdocument of 6 observations
Cervical cancer related to high-risk human papillomavirus is the second female cancer in Mauritania.
Mauritaniecancer du col de l'utéruspublished 2024Diagnostics (Basel, Switzerland)PubMeddocument of 10 observations
6 %The prevalence of diabetes mellitus is 6% in Mauritania.
Mauritaniediabète (non précisé)HAL · Unilimdocument of 97 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.